Authors
Loading...
Randomized trial assesses oral bioavailability and cytotoxicity of NLT-loaded spanlastics in chronic myeloid leukemia, suggesting improved treatment outcomes.
Hamzah et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: